Gaush Meditech Ltd. Board announced that Ms. Li Wenq (Ms. Li), currently the vice president (the Vice President) and a joint company secretary of the Company, has been appointed as the Chief Financial Officer with effect from January 10, 2023. Mr. Liu Xinwei new role as the Co-CEO, Mr. Liu has ceased to act as the Chief Financial Officer with effect from January 10, 2023. Ms. Li has confirmed that she has no disagreement with the Board and she is not aware of any matters in connection with her resignation of the Vice President that need to be brought to the attention of the shareholders of the Company or The Stock Exchange of Hong Kong Limited. Ms. Li, aged 49, has over 20 years of experience in accounting and financial management. She first joined the Global Vision Corporation, a wholly owned subsidiary of the Company, in August 1998 and served successively as cashier, accountant, financial supervisor, financial manager and financial controller. She has served as the Vice President from January 2018 to January 2023 and was appointed as a joint company secretary of the Company on November 18, 2021. Ms. Li received her bachelor's degree in accounting from Beijing Wuzi University in the PRC in July 1995. She also obtained accounting specialist qualification conferred by the Ministry of Finance of the PRC in May 1999. Mr. Liu, aged 41, has around nine years of experience in the medical industry. Mr. Liu joined the Group as the board secretary of Gaush Medical Corporation, a wholly owned subsidiary of the Company, in May 2016. Mr. Liu served as the Chief Financial Officer from December 2018 to January 2023. He has served as a Director since November 21, 2019 and was re-designated as an executive Director on November 18, 2021. Mr. Liu also holds directorship in Gaush Europe GmbH, Gaush Coöperatief U.A. and Gaush Teleon Ltd, all of which are wholly owned subsidiaries of the Company. Before joining the Group, from April 2013 to March 2016, Mr. Liu served as assistant to the president of Beijing Naton Group Co. Ltd. Mr. Liu received his master degree in business administration from Tsinghua University in July 2013. He received his bachelor degree in information engineering from Zhejiang University in June 2004. Mr. Liu holds a legal professional qualification certificate issued by the Ministry of Justice of the People's Republic of China (the PRC) in March 2013 and became a non-practising member of the Beijing Institute of
Certified Public Accountants in April 2017.
Gaush Meditech Ltd is a China-based company mainly engaged in ophthalmology medical business. The Company operates in four segments. Proprietary Products segment develops and produces surgical equipment and related supporting software, intra optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables. Distribution segment sells brand ophthalmic medical devices and consumables. Technical Services segment provides warranty service, maintenance service and consumables related to after-sales service. Others segment is mainly engaged in equipment leasing business and intellectual property agency services. The Company's products are widely used in the examination, treatment and correction of ophthalmic subspecialty diseases such as fundus disease, cataract, glaucoma, refraction, optometry, ocular surface, and children's ophthalmology.
GAUSH MEDITECH LTD 
